This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

4 Biotech Stocks Under $5 Moving Higher

Stocks in this article: OREX PSTI CDXS KERX

Orexigen Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Orexigen Therapeutics (OREX) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. This stock is trading up 7.6% to $4.95 in recent trading.

Today's Range: $4.65-$5.14

52-Week Range: $1.26-$7.73

Volume: 2.9 million

Three-Month Average Volume: 4.1 million

Shares of OREX are ripping higher today in front of its presentation at an investor conference on Wednesday, and after it released related information about its ongoing drug studies ahead of the meeting.

>>5 Rocket Stocks Worth Buying This Week

From a technical perspective, OREX is bouncing sharply here right off some near-term support at $4.50 with decent volume. This move is quickly pushing OREX within range of triggering a major breakout trade. That trade will hit once OREX clears some near-term overhead resistance at $4.85, and then once it takes out its 50-day moving average of $5.11 with high volume. At last check, OREX has hit an intraday high of $5.14 and volume is about 1 million shares below its three-month average action of 4,075,770 shares.

Traders should now look for long-biased trades in OREX once it sustains a move or close above $4.85 to $5.11 with volume that's near or above 4.1 million shares. If that breakout triggers soon, then OREX has a great chance of heading north of $6, and possibly tagging its July high of $7.73. Traders should key off of $4.50 to $4.30 as support zones if you buy off weakness.

3 of 5

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs